You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
據報內地已啟動第七批藥品集中帶量採購工作 涉59個品種
據《21世紀經濟報道》報道,第七批國家集中帶量採購工作已啟動。據業內流傳的一份由國家組織藥品聯合採購辦公室發布的《關於報送第七批國家組織藥品集中採購品種範圍相關採購數據的通知》顯示,第七批國採共涉及59個品種,208個品規。其中不乏奧美拉唑注射劑、美羅培南、美托洛爾等億元量級的大品種。 通知顯示,今日正式啟動報量,各省導入2021年歷史採購量數據供醫療機構參考,醫療機構須按要求填報相關藥品採購需求量,並於2月16日24:00前提交數據。2月25日17:00前,各省需要完成相關藥品採購需求量審核工作。(ta/w) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account